companydata.dkcompanydata.dk

Hoba Therapeutics ApS: Financial statements 2025

CVR: 38231170

Source: annual report 2025, Danish Business Authority

01/04/2024 – 31/03/2025

Hoba Therapeutics ApS (CVR 38231170) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -38,348,438 and a net result of DKK -43,008,287 compared with DKK -27,806,718 the year before. Equity in the 2025 report amounted to DKK 26,061,902. The solvency ratio was 56.5%. The company had 8 employees in the financial year.

Gross Profit
DKK -38,348,438
Profit/Loss
DKK -43,008,287
Equity
DKK 26,061,902
Total Assets
DKK 46,100,229
Employees
8

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--38.3M-43M26.1M8
2024--20.9M-27.8M69.1M8
2023--9.4M-13.9M-32.9M6
20220-7.2M-10.9M-19M3
2021-1.4M-1.9M8.2M3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Hoba Therapeutics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Jean Marcel André Combalbert joins Hoba Therapeutics ApS as adm. dir.Sep 19, 2025

As of September 19, 2025, Jean Marcel André Combalbert is registered as adm. dir. of Hoba Therapeutics ApS.

Torsten Meldgaard Madsen steps down as adm. dir. of Hoba Therapeutics ApSSep 19, 2025

As of September 19, 2025, Torsten Meldgaard Madsen has stepped down as adm. dir. of Hoba Therapeutics ApS.

Registered as owner of Hoba Therapeutics ApSSep 1, 2025

As of September 1, 2025, is registered as an owner of Hoba Therapeutics ApS with an ownership share of 20%.

Registered as owner of Hoba Therapeutics ApSSep 1, 2025

As of September 1, 2025, is registered as an owner of Hoba Therapeutics ApS with an ownership share of 10%.

Kuang He joins the board of Hoba Therapeutics ApSJan 21, 2025

As of January 21, 2025, Kuang He has joined the board of directors of Hoba Therapeutics ApS.

Marie Allen Schroeder leaves the board of Hoba Therapeutics ApSJan 21, 2025

As of January 21, 2025, Marie Allen Schroeder has left the board of directors of Hoba Therapeutics ApS.

About Hoba Therapeutics ApS

Hoba Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade. The board consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade (chair) and Gunnar Magnus Severus Modée Persson. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and EIC Fund. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK -61,710,701 and a net result of DKK -67,693,868 compared with DKK -43,008,287 the year before. Equity in the 2026 report amounted to DKK 1,143,899.

Source: annual report 2026, Danish Business Authority